ELIXIRGEN THERAPEUTICS, INC. — Form D
ELIXIRGEN THERAPEUTICS, INC. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-01. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-01
- Form: D
- Accession: 0001744333-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 1
- Date of first sale: 2023-11-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-498657
Issuer
- Name: ELIXIRGEN THERAPEUTICS, INC.
- CIK: 0001744333
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 855 N. WOLFE ST., BALTIMORE, MD, 21205
- Phone: 443-451-5300
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Shauna K Callahan | Director | Baltimore, MD |
| Jeffrey K Cleland | Director | Baltimore, MD |
| Akihiro C Ko | Director | Baltimore, MD |
| Minoru SH Ko | Director | Baltimore, MD |
| Hiroaki C Kobayashi | Director | Baltimore, MD |
| Thomas K White | Director | Baltimore, MD |
| Akihiro C Ko | Executive Officer | Baltimore, MD |
| HIROAKI KOBAYASHI | Director | BALTIMORE, MD |
| THOMAS WHITE | Director | BALTIMORE, MD |
| JEFFREY CLELAND | Director | BALTIMORE, MD |
| MINORU KO | Director | BALTIMORE, MD |
| MINORU KO | Executive Officer | BALTIMORE, MD |
| SHAUNA CALLAHAN | Director | BALTIMORE, MD |
| AKIHIRO KO | Director | BALTIMORE, MD |
| AKIHIRO KO | Executive Officer | BALTIMORE, MD |
| AKIHIRO KO | Promoter | BALTIMORE, MD |
| Maiko Katadae | Director | Baltimore, MD |
| Naonori Kurokawa | Director | Baltimore, MD |
Other filings by this issuer (8)
More